Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 71731-5111

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 71731-5111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (M01 Carton)

Carton label for Fosaprepitant injection, 150 mg per vial, a sterile lyophilized powder for intravenous use after reconstitution with 5 mL 0.9% sodium chloride. Manufactured by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. The label includes warnings about solutions containing divalent cations, active and inactive ingredient information, storage requirements, and single-dose vial instructions.*

FDA Label Image

Chemical Structure (M01 Chemical Structure)

Chemical structure diagram of Fosaprepitant dimeglumine, the active ingredient in FOSAPREPITANT injection, powder, lyophilized for solution, 150 mg/5 mL by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.